// App-Quantinova.ai

668 : Risk Factors, Treatment and Outcome of 2nd Relapse of Acute Lymphoblastic Leukemia in Children. Results of the ALL-REZ BFM Registry

Researchers

Presenter

  • Valentijn Bon

Principal Investigators

  • Andre Schrauder

  • Christina Peters

  • EBMT-PDWP

  • Gunter Henze

  • Arend von Stackelberg

Medical Centers

  • Stem Cell Transplantation Unit, St. Anna Children's Hospital & Pediatric Oncology and Hematology, Charite Universitatsmedizin Berlin, Berlin, Germany

  • Vienna, Austria

  • Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany

Locations

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Daunorubicin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved